MOD vs NBIX · P/E 126, rev $2.58B vs P/E 45, rev $2.36B
Modine Manufacturing Company (MOD) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Modine Manufacturing Company (MOD) is a auto parts company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MOD revenue for 2025-03-31 was $2.58B. Net income was $185.5M. Revenue was up 7.3% from 2024-03-31 to 2025-03-31. MOD currently screens at market cap $14.99B and trailing P/E 126.2.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
MOD currently screens at market cap $14.99B and trailing P/E 126.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the MOD and NBIX stock pages for the full models.
Not investment advice.